Transaction DateRecipientSharesTypePriceValue
6th November 2020Stephen P Ewald10,518Exercise of derivative$14.41$151,564.38
8th October 2020Susan E Burwig20,000Exercise of derivative$14.41$288,200.00
6th October 2020August J. Troendle50,000Exercise of derivative$23.00$1,150,000.00
5th October 2020August J. Troendle2,592Exercise of derivative$16.20$41,990.40
5th October 2020August J. Troendle1,851Exercise of derivative$14.41$26,672.91
5th October 2020Investors, Llc Medpace2,592Exercise of derivative$16.20$41,990.40
5th October 2020Investors, Llc Medpace1,851Exercise of derivative$14.41$26,672.91
1st September 2020Jesse J Geiger3,110Open or private sale$130.00$404,300.00
1st September 2020Jesse J Geiger3,110Exercise of derivative$23.00$71,530.00
31st August 2020Jesse J Geiger3,700Exercise of derivative$23.00$85,100.00
Medpace Holdings
Medpace Holdings logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 3/10.

Medpace Holdings, Inc. provides outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.

Ticker: MEDP
Sector: Healthcare
Industry: Diagnostics & Research
SEC Central Index Key (CIK): 1668397
Employees: 2900
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Cash at Carrying Value: $161 M (21%)
Receivables, Net, Current: $127 M (0%)
Assets, Current: $319 M (0%)
Property, Plant and Equipment, Net: $66 M (39%)
Other Assets, Noncurrent: $10 M (8%)
Assets: $1 B (6%)
Accounts Payable, Current: $15 M (-33%)
Accrued Liabilities, Current: $103 M (0%)
Liabilities, Current: $338 M (-1%)
Other Liabilities, Noncurrent: $16 M (0%)
Liabilities: $484 M (16%)
Common Stock, Value, Issued: $354 Th (-1%)
Common Stock, Shares, Issued: $35 M (-1%)
Additional Paid in Capital, Common Stock: $677 M (1%)
Retained Earnings (Accumulated Deficit): $70 M (3%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $3 M (17%)
Treasury Stock, Value: $60 Th (0%)
Treasury Stock, Shares: $2 M (0%)
Stockholders' Equity (Parent): $738 M (0%)
Liabilities and Equity: $1 B (6%)
Revenue: $205 M (-52%)
Operating Income/Loss: $30 M (-54%)
Other Income, net: $234 Th (-80%)
Provision for income taxes: $6 M (-54%)
EPS (basic): $0.68 (0%)
EPS (diluted): $0.64 (0%)